Sign up for weekly longevity biotechnology investing analysis. By Nathan Cheng.
Oxford Venture Network Event with Sebastian Brunemeier.
Nathan Cheng
OneSkin topical senolytic. Oxford Venture Capital Event. BONUS Database Access.
Nathan Cheng
Biogen rollercoaster. CRISPR Therapeutics patient death.
Nathan Cheng
Biotech Modality Cheat Sheet. Capital Markets Panel @ Metabesity 2020. Calico's first trial. Top finds.
Nathan Cheng
AgeX price soars. Gensight Biologics and ChromaDex positive trial data. Technical Analysis.
Nathan Cheng
Mesoblast FDA Rejection. Longevity stocks on CNBC.
Nathan Cheng
a16z's newest podcast series. Bubble roadmap. Technical Analysis.
Nathan Cheng
See all

LongevityMarketcap Newsletter